GWP
CRBU icon

Gen-Wealth Partners’s Caribou Biosciences CRBU Stock Holding History

Gen-Wealth Partners’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258 Hold
136
– – ﹤0.01% 710
2025
Q4 		$216 Hold
136
– – ﹤0.01% 679
2025
Q3 		$317 Hold
136
– – ﹤0.01% 669
2025
Q2 		$171 Hold
136
– – ﹤0.01% 634
2025
Q1 		$124 Hold
136
– – ﹤0.01% 610
2024
Q4 		$216 Hold
136
– – ﹤0.01% 639
2024
Q3 		$268 Hold
136
– – ﹤0.01% 647
2024
Q2 		$223 Hold
136
– – ﹤0.01% 633
2024
Q1 		$699 Buy
+136
New +$839 ﹤0.01% 592

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gen-Wealth Partners's CRBU Position: Q1 2026 in Review

Gen-Wealth Partners held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 136 shares worth $258. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Gen-Wealth Partners first reported a position in CRBU in Q1 2024 and has held it in 9 quarters since. The position peaked at $699 in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Gen-Wealth Partners held 136 shares of Caribou Biosciences worth $258 as of Q1 2026.
  • Gen-Wealth Partners left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Gen-Wealth Partners's portfolio in Q1 2026, its #710 holding.
  • Gen-Wealth Partners first reported a position in Caribou Biosciences in Q1 2024 and has held it in 9 quarters since.
  • Gen-Wealth Partners's Caribou Biosciences position peaked at $699 in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Gen-Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.